CopyFind
Meprelone 4mg Tablet
medicine 📍 IN

Meprelone 4mg Tablet

55,00 ₹

Аналоги Meprelone 4mg Tablet

Найдите более доступные аналоги и дженерики для Meprelone 4mg Tablet.

Ингредиенты

Активный ингредиент: Methylprednisolone


Описание товара

About Meprelone

Meprelone is a medication containing the active ingredient Methylprednisolone, classified as Corticosteroid medication. Methylprednisolone, sold under the brand name Medrol among others, is a synthetic glucocorticoid, primarily prescribed for its anti-inflammatory and immunosuppressive effects. It is either used at low doses for chronic illnesses or used at high doses during acute flares.

Key Benefits & Uses

  • Used for: INDICATIONS AND USAGE Methylprednisolone tablets are indicated in the following conditions: 1
  • Used for: Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice
  • Used for: synthetic analogs may be used in conjunction with mineralocorticoids where applicable

Active Ingredient & Action

Methylprednisolone, the active ingredient in Meprelone, belongs to the Corticosteroid medication class. INDICATIONS AND USAGE Methylprednisolone tablets are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy minera…. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Meprelone. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Meprelone for extended periods without medical advice.

Найти в аптеках

Сравните местные цены и расстояние для Meprelone 4mg Tablet.

Оценки посетителей

Помогите другим — оцените полезность этой страницы.

Оценок пока нет — будьте первым.